# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...
RBC Capital analyst Frank Morgan maintains Humana (NYSE:HUM) with a Outperform and lowers the price target from $415 to $353.
UBS analyst Kevin Caliendo maintains Humana (NYSE:HUM) with a Neutral and lowers the price target from $334 to $326.
Cantor Fitzgerald analyst Sarah James maintains Humana (NYSE:HUM) with a Neutral and lowers the price target from $391 to $360.